Jitendra Shrawan Kanodia

7PUBLICATIONS
28CO-AUTHORS
PharmacogenomicsInformation systems philosophy, research methods and theoryCancer therapy (excl. chemotherapy and radiation therapy)Information systems development methodologies and practiceInnate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Feb 23, 2025
Opportunities and Challenges of Hepatic Impairment Physiologically Based Pharmacokinetic Modeling in Drug Development-An IQ Perspective.

Hisham Qosa, Islam R Younis, Vaishali Sahasrabudhe

|Oct 23, 2024
An IQ Industry Perspective on Informing Dosing Recommendations in Patients With Renal Impairment.

Ashish Sharma, Islam R Younis, Jitendra Kanodia

|May 16, 2024
Dose Optimization in Oncology Drug Development: An International Consortium for Innovation and Quality in Pharmaceutical Development White Paper.

Divya Samineni, Karthik Venkatakrishnan, Ahmed A Othman

|Mar 27, 2024
Impact of COVID-19 on the Conduct and Design of Clinical Trials: IQ Consortium Perspective.

Mohamed-Eslam F Mohamed, Sandhya Girish, Rita Humeniuk

|Jan 18, 2023
International consortium for innovation and quality: An industry perspective on the nonclinical and early clinical development of intravitreal drugs.

Ingrid M Pruimboom-Brees, Swati Gupta, Nagendra Chemuturi

|Mar 30, 2021
Pharmacokinetics and pharmacodynamics of ampreloxetine, a novel, selective norepinephrine reuptake inhibitor, in symptomatic neurogenic orthostatic hypotension.

Arthur Lo, Lucy Norcliffe-Kaufmann, Ross Vickery

Pageof 2

Frequent Collaborators

2 joint publications

Arthur Lo

2 joint publications

Vaishali Sahasrabudhe

2 joint publications

Islam R Younis

2 joint publications

Ashish Sharma